Ratings AMOREPACIFIC Group

Equities

A002790

KR7002790004

End-of-day quote Korea S.E. 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
35,500 KRW +2.01% Intraday chart for AMOREPACIFIC Group +9.40% +21.37%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company is in a robust financial situation considering its net cash and margin position.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 684.45 for the 2024 fiscal year.
  • The company appears to be poorly valued given its net asset value.
  • The company has a low valuation given the cash flows generated by its activity.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Personal Products

1st Jan change Capi. Investor Rating ESG Refinitiv
+21.37% 2.1B
B+
+1.22% 264B
B-
+18.26% 20.44B
B+
+11.36% 12.29B
A-
-11.84% 9.5B
A-
+16.55% 7.6B
B+
+13.64% 6.16B
B
-8.41% 4.24B
B+
-14.99% 3.92B
C-
-7.58% 3.67B
B
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. A002790 Stock
  4. Ratings AMOREPACIFIC Group
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW